180160-40-1 Usage
General Description
6-chloro-3H-spiro[isobenzofuran-1,4'-piperidin]-3-one is a chemical compound with the molecular formula C13H14ClNO2. It is a spiro lactam derivative with a piperidine ring and a chlorine atom attached to the 6th position of the benzene ring. 6-chloro-3H-spiro[isobenzofuran-1,4'-piperidin]-3-one has applications in the field of medicinal chemistry and pharmaceuticals. It exhibits potential biological activities and has been studied for its pharmacological properties, including anti-tumor and analgesic effects. Additionally, it has been investigated as a potential drug candidate for the treatment of various diseases. The chemical structure of 6-chloro-3H-spiro[isobenzofuran-1,4'-piperidin]-3-one makes it a valuable building block for the synthesis of novel compounds with therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 180160-40-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,1,6 and 0 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 180160-40:
(8*1)+(7*8)+(6*0)+(5*1)+(4*6)+(3*0)+(2*4)+(1*0)=101
101 % 10 = 1
So 180160-40-1 is a valid CAS Registry Number.
180160-40-1Relevant articles and documents
INDOL-3-YL-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS
-
Page/Page column 37; 39, (2008/06/13)
The invention relates to indol-3-yl-carbonyl-spiro-piperidine derivatives which act as V1a receptor antagonists and which are represented by Formula I: wherein the spiro-piperidine head group A and the residues R1, R2 and R3 are as defined herein. The invention further relates to pharmaceutical compositions containing such compounds, methods for preparing the compounds and pharmaceutical compositions, and their use in the treatment of dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder, anxious and depressive disorders.